AI-CVD vs Tyto Stethoscope

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI-CVD

by HeartLung Corporation

Tyto Stethoscope

by Tyto Care

AI Verdict

AI-CVD is an AI-powered quantitative imaging platform that screens for cardiovascular and multisystem diseases using existing CT scans, focusing on early detection of hidden risks through automated measurements. In contrast, the Tyto Stethoscope is an AI-powered, all-in-one modular device and platform for remote medical exams, enabling comprehensive virtual visits for various conditions including heart and lungs through digital auscultation and imaging. While both leverage AI for cardiovascular assessment, AI-CVD focuses on opportunistic screening from existing imaging data, whereas Tyto Stethoscope facilitates real-time remote physical examinations.

Choose AI-CVD if…

Choose AI-CVD if your primary goal is to leverage existing CT scans for opportunistic, early detection of a broad range of cardiovascular and multisystem diseases. This tool is ideal for healthcare systems looking to enhance screening capabilities without additional imaging, radiation, or workflow disruption, providing automated measurements for conditions like coronary artery calcium, cardiac chamber volumetry, and epicardial fat volumetry.

View AI-CVD →

Choose Tyto Stethoscope if…

Choose Tyto Stethoscope if you need a comprehensive, AI-powered remote medical exam solution for virtual visits, enabling patients to perform guided self-examinations from home. This tool is best suited for telehealth providers and patients seeking to conduct remote physical exams of the heart, lungs, ears, throat, and skin, along with vital sign measurements, to facilitate virtual diagnoses and treatment plans.

View Tyto Stethoscope →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AI-CVD	Tyto Stethoscope
Pricing	Contact for pricing	Tytohome: ~$299-$300 (one-time purchase); tytopro: $999 + undisclosed monthly subscription.
Deployment	Cloud	Cloud-based platform with a handheld medical device and mobile application.
FDA Status	1 AI-estimated	1 AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tyto Stethoscope

Tyto Stethoscope is designed for remote medical exams with a handheld device and mobile app, offering guided examination processes and clear instructions, making it highly accessible for patients and caregivers in various settings. AI-CVD, while providing automated analysis of CT scans, is a platform for healthcare providers and doesn't emphasize direct patient usability in the same way.

Clinical Value

Tyto Stethoscope

Tyto Stethoscope offers comprehensive remote physical exams for multiple body areas (heart, lungs, ears, throat, skin, abdomen) and measures vital signs, enabling virtual visits and AI-powered diagnostics for conditions like wheeze, crackles, and rhonchi detection. AI-CVD focuses on opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, providing valuable risk stratification for conditions like coronary artery disease, heart failure, and stroke. However, TytoCare's broader diagnostic capabilities for immediate virtual care give it a slight edge in direct clinical utility for a wider range of common conditions.

Pricing & Value

Tyto Stethoscope

Tyto Stethoscope offers transparent pricing for its consumer version (TytoHome) at approximately $299-$300, with a professional version (TytoPro) at $999 plus a subscription. AI-CVD's pricing is not publicly disclosed, requiring direct contact with the vendor, which makes it difficult to assess its value proposition without further inquiry.

Enterprise Readiness

Tyto Stethoscope

Tyto Stethoscope has a clear deployment model involving a cloud-based platform, handheld device, and mobile application, with explicit HIPAA compliance and BAA availability, indicating strong enterprise readiness for telehealth integration. AI-CVD is also cloud-deployed and likely HIPAA compliant with BAA, but the nature of its integration into existing radiology workflows for opportunistic screening might require different considerations compared to TytoCare's direct patient and provider interaction model.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. AI-CVD innovates by leveraging existing CT scans for opportunistic, multi-system disease screening without additional imaging, radiation, or workflow disruption. Tyto Stethoscope innovates by providing an all-in-one modular device for comprehensive remote physical exams, integrating AI for diagnostic support in a virtual care setting. Their innovative approaches are distinct but equally impactful within their specific healthcare niches.

Support & Docs

Tyto Stethoscope

Tyto Stethoscope provides readily available support resources, including FAQs, troubleshooting guides, and direct contact information for technical support. The device also has built-in training videos and technology to guide users. Information regarding AI-CVD's specific support and documentation was not readily available in the provided facts or through general web searches, making it difficult to assess its offerings in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AI-CVD	Tyto Stethoscope
Tool Name	AI-CVD	Tyto Stethoscope
Company	HeartLung Corporation	Tyto Care
Description	FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks.	AI-powered, all-in-one modular device and platform for remote medical exams, enabling comprehensive virtual visits for heart, lungs, ears, throat, and skin, along with vital sign measurements.
Categories	Cardiology AI	Cardiology AI, Telehealth & Virtual Care, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Pulmonology, Radiology	Family Medicine, Internal Medicine, Pediatrics
Key Features	Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing	Remote physical exams (heart, lungs, ears, throat, skin, abdomen), Measures heart rate and body temperature, High-quality digital sounds, images, and video capture, Guided examination process with on-device and in-app instructions, Supports live and asynchronous telehealth workflows, AI-powered diagnostics and clinical decision support (e.g., lung sound identification), HIPAA-compliant cloud storage and encrypted data transmission, Mobile application for iOS and Android devices

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Tyto Stethoscope.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems, and what level of data exchange can physicians expect?

AI-CVD integrates with existing CT scan workflows to opportunistically screen for cardiovascular and multisystem diseases, leveraging existing imaging data. Tyto Stethoscope, as a remote examination platform, captures and stores high-quality digital sounds, images, and video, which can be integrated into telehealth workflows for comprehensive virtual visits. Both tools are cloud-based, suggesting potential for API-driven integration with EHRs, though the depth of integration would likely vary based on the specific EHR system and vendor partnerships.

Given their different functionalities, how do AI-CVD and Tyto Stethoscope contribute to diagnostic accuracy and sensitivity in their respective clinical contexts?

AI-CVD offers automated, quantitative measurements from CT scans for early detection of hidden cardiovascular risks, including coronary artery calcium scoring and cardiac chamber volumetry, enhancing diagnostic sensitivity for opportunistic screening. Tyto Stethoscope provides high-quality digital capture of heart and lung sounds, images, and video during remote exams, along with AI-powered diagnostics like lung sound identification, aiming to improve diagnostic accuracy in virtual care settings by providing objective data.

What is the typical learning curve for physicians and their staff to effectively utilize each tool in their daily practice?

AI-CVD, by leveraging existing CT scans, likely has a minimal learning curve for physicians as it integrates into existing radiology workflows and provides automated analysis. Tyto Stethoscope, with its handheld device and guided examination process, would require some initial training for both physicians and patients to ensure proper use for remote physical exams, though its intuitive design aims to simplify this process.

Can these tools provide audit trails for clinical decisions or data interpretation, which is crucial for accountability and quality assurance?

AI-CVD, by providing automated quantitative measurements from CT scans, inherently creates a digital record of its analysis, which can serve as an audit trail for opportunistic screening findings. Tyto Stethoscope's platform captures and stores digital sounds, images, and video from remote exams, along with AI-powered diagnostic support, creating a comprehensive record of the virtual visit that can be reviewed for audit purposes.

How do these tools support multi-site rollouts for larger healthcare systems or practices with multiple locations?

Both AI-CVD and Tyto Stethoscope are cloud-based, which inherently facilitates multi-site rollouts by centralizing data and access. AI-CVD can be integrated across various imaging centers within a system, while Tyto Stethoscope's remote examination capabilities and cloud platform are well-suited for deployment across multiple clinics or even for patients in diverse locations, streamlining virtual care delivery across an organization.

What kind of customer support and resources are available to physicians for ongoing assistance and optimization of these tools?

While specific details on support quality are not provided, both companies would likely offer technical support and resources. HeartLung Corporation, with its specialized AI-CVD platform, would likely provide expert support for integration and interpretation of its advanced imaging analytics. Tyto Care, offering a comprehensive remote examination platform, would likely provide support for device usage, platform navigation, and telehealth workflow optimization, potentially including training materials and customer service for both providers and patients.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring AI-CVD or Tyto Stethoscope

Backers

Who funded each tool's parent company.